Clinical data | |
---|---|
Other names | 11α-Methoxyethinylestradiol; 11α-Methoxy-17α-ethynylestradiol; 11α-Methoxy-19-nor-17α-pregna-1,3,5(10)-trien-20-yne-3,17-diol |
Routes of administration | By mouth[1] |
Drug class | Estrogen; Estrogen ether |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C21H26O3 |
Molar mass | 326.436 g·mol−1 |
3D model (JSmol) | |
| |
|
RU-16117 is an estrogen medication which was investigated for the potential treatment of symptoms of estrogen deficiency such as hot flashes and osteoporosis in women but was never marketed.[1] It was developed for use by mouth.[1]